{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q01105",
      "entity_text" : "TAFI",
      "entity_type" : "protein"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uniprot:P07204",
      "entity_text" : "thrombomodulin",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "uaz:UAZ03241",
      "entity_text" : "plasmin",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "Recent reports also detailed the usefulness of thrombomodulin in treatment of APL associated coagulopathy [XREF_BIBR - XREF_BIBR]; it binds to plasmin to activate thrombin-activatable fibrinolytic inhibitor (TAFI), thereby inhibiting fibrinolysis [XREF_BIBR - XREF_BIBR].",
  "reading_complete" : "2020-08-04T15:59:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T15:57:33Z",
  "trigger" : "activate",
  "evidence" : [ "it binds to plasmin to activate thrombin-activatable fibrinolytic inhibitor (TAFI" ],
  "pmc_id" : "5985706",
  "score" : 0
}